Eirik Næss-Ulseth • 1956 • Oslo • 16 roles • 14 shareholdings

This website uses cookies to enhance the user experience.

||

Roles

Management

Name	Role	Total operating income	Total equity	Shares
S SHARPXVIEW AS	Managing Director/CEO	1,310,800	719,381	30 % indirectly

Boards

Name	Role	Total operating income	Total equity	Shares
S SKILLING SYSTEMER AS	Chairman	796,800	7,858,408	60 % directly
C CELLMOVER AS	Board Member	4,496,766	749,553	51.12 % directly 29.41 % indirectly 21.71 %
I INVENTRON AS	Chairman	-	123,077	32.96 % indirectly
S SHARPXVIEW AS	Chairman	1,310,800	719,381	30 % indirectly
E EQUANOSTIC AS	Chairman	10,429,112	645,861	23.43 % indirectly
V VITAE EVIDENCE AS	Board Member	574,194	3,224,940	22.9 % directly 1.41 % indirectly 21.49 %
C COREMINE VITAE AS	Chairman	2,069,446	1,691,173	22.61 % directly 0.15 % indirectly 22.46 %
A ARCTIC PHARMA AS	Chairman	1,018,191	2,005,323	22.08 % indirectly
T TOBORA AS	Board Member	-	19,539	15 % indirectly
B BIOMOLEX AS	Chairman	301,048	-244,697	11.88 % directly 2.4 % indirectly 9.47 %
S SPERMATECH AS	Board Member	443,352	304,768	11.21 % indirectly
C COREMINE BIL	Board Member	-	-	-
P PUBGENE AS	Chairman	2,894,213	18,960,345	-
H HECOTRON AS	Alternate Member	-	5,778,387	-
H HECOTRON INDUSTRIELL ELEKTRONIKK AS	Board Member	30,411,410	10,634,848	-

Last update: Jun 11, 2025

Related industries4

Direct relationships5

HH
Håvard Hildeng Hauge1969
COREMINE BIL, PUBGENE AS, BIOMOLEX AS, VITAE EVIDENCE AS, COREMINE VITAE AS
BS
Bjørn Steen Skålhegg1959
ARCTIC PHARMA AS, SPERMATECH AS, TOBORA AS
GH
Gunnar Hvammen1963
ARCTIC PHARMA AS, SPERMATECH AS
EM
Espen Marcelius Gjems1978
COREMINE BIL, SPERMATECH AS
EN
Einar Nygård1962
INVENTRON AS, SHARPXVIEW AS

Shares owned by Eirik Næss-Ulseth

Name	Share class	Total operating income	Total equity	Share
S SKILLING SYSTEMER AS	Ordinære aksjer	796,800	7,858,408	60 % directly
I INVENTRON AS		0	123,077	32.96 % indirectly
S SHARPXVIEW AS		1,310,800	719,381	30 % indirectly
C CELLMOVER AS	Ordinære aksjer	4,496,766	749,553	29.41 % directly 29.41 % indirectly 21.71 %
E EQUANOSTIC AS		10,429,112	645,861	23.43 % indirectly
A ARCTIC PHARMA AS		1,018,191	2,005,323	22.08 % indirectly
R RHEUMATECH AS		58,948	-876	15.58 % indirectly
S SKIPLUKKERN AS		7,430,425	2,258,864	15 % indirectly
T TOBORA AS		0	19,539	15 % indirectly
S SPERMATECH AS		443,352	304,768	11.21 % indirectly
R RAFX TECHNOLOGIES AS		1,633,692	182,942	5.95 % indirectly
B BIOMOLEX AS	NO0010162266	301,048	-244,697	2.4 % directly 2.4 % indirectly 9.47 %
V VITAE EVIDENCE AS	Ordinære aksjer	574,194	3,224,940	1.41 % directly 1.41 % indirectly 21.49 %
C COREMINE VITAE AS	Ordinære aksjer	2,069,446	1,691,173	0.15 % directly 0.15 % indirectly 22.46 %

Limited to direct ownership positions of 0.5% or more.

Last update: Jun 2, 2025